最新报道:Injective (INJ) token dropped 5% amid market volatility, despite a recent surge triggered by BlackRock's Bitcoin ETF filing. The token had gained over 250% in the past month, reaching a high of $16.50 before correcting to $15.20. Analysts attribute the pullback to profit-taking after the rally, with some investors rotating into Bitcoin following the ETF news. Injective's ecosystem growth, including new DeFi integrations, continues to attract long-term holders. Market watchers note the token remains 80% below its all-time high, suggesting potential upside if adoption accelerates.